SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001687888-19-000004
Filing Date
2019-05-31
Accepted
2019-05-31 16:14:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 NVLN 13G NVLN_13G_20190531.htm SC 13G 42477
  Complete submission text file 0001687888-19-000004.txt   44322
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43381 | Film No.: 19870598
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734
Business Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734 5127614500
JFL Capital Management, LLC (Filed by) CIK: 0001687888 (see all company filings)

IRS No.: 472302073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G